Assessment and management of cannabis use disorders in primary care
Effectiveness bank home page. Opens new windowReview abstract

This entry is for a review or synthesis of research findings added to the Effectiveness Bank but not fully analysed. Usually the entry consists only of the reference and an edited version of the original abstract, with either no commentary from Drug and Alcohol Findings or only essential points. The original review was not published by Findings; click Title to order a copy. Free reprints may be available from the authors – click prepared e-mail.

Links to other documents. Hover over for notes. Click to highlight passage referred to. Unfold extra text Unfold supplementary text
Copy title and link | Comment/query |

Assessment and management of cannabis use disorders in primary care.

Winstock A.R., Ford C., Witton J.
BMJ: 2010, 340, p. 800–904.
Unable to obtain a copy by clicking title? Try asking the author for a reprint by adapting this prepared e-mail or by writing to Dr Winstock at

A brief clinical review outlining the harms associated with cannabis use, and the optimal approaches for assessing and managing problem cannabis use in UK primary care.

Summary Two major diagnostic manuals recognise cannabis as a substance that can cause dependence. This is thought to happen in about one in ten users, and can be identified by a cluster of symptoms including: loss of control; inability to cut down or stop; preoccupation with use; neglecting activities unrelated to use; continued use despite experiencing problems related to use; and the development of tolerance and withdrawal.

No intervention to date has proved consistently effective for the majority of those with cannabis dependence, though trials in the United States and Australia support four methods of behavioural-based interventions: motivational interviewing; motivational enhancement therapy; cognitive-behavioural therapy; and contingency management. For younger users, evidence suggests family-based interventions may be the most effective.

How practitioners can respond to cannabis use problems


In primary care, cannabis use can be initially raised as part of a discussion between practitioner and patient about healthy lifestyles, for example along with the issues of cigarette smoking, drinking, mental health, and sleep. Questions to identify potential problems could include:
• How long does a gram (or an eighth of an ounce) last you? How many joints a day do you smoke? How many joints do you make from a gram?
• On how many days a week or month do you smoke?
• Do you mix it with tobacco? Do you smoke cigarettes as well?
• Does your cannabis use cause you any problems, such as anxiety, a cough, interference with your sleep or appetite?
• Does your smoking ever interfere with what you want to do or what you have to do, such as working or studying?
• Have you ever thought about cutting down or stopping?
• Have you ever tried to cut down or stop? What happened? Were you able to sleep? Do you get irritable or moody?
• If you managed to stop for a while, how did you feel afterwards?

Asking the patient to draw up a pros and cons table can be good way to get them to think about their use, as can a motivational approach to explore and resolve ambivalence about cannabis use. If a patient’s cannabis use does not seem to be impairing their psychosocial functioning, the intervention can be restricted to giving health information and discussing risks.

Symptoms of withdrawal (eg, not being able to relax, and not sleeping as well) may be a barrier to stopping or reducing cannabis use. These can be more severe in people with overlapping mental health issues, or people who are also heavy cigarette smokers.

Guidance for managing withdrawal includes:
• Advising gradual reduction in amount of cannabis used before stopping altogether.
• Suggesting that the patient delays first use of cannabis until later in the day.
• Suggesting that the patient considers use of nicotine replacement therapy if he or she plans to stop cigarette smoking at the same time.
• Advising the patient on good sleep habits, including avoidance of caffeine, which may exacerbate irritability, restlessness, and insomnia.
• Suggesting activities that relax or distract the patient.
• Suggesting psychoeducation sessions for the user and family members on the nature, duration, and severity of withdrawal, to help with a better understanding of dependence and reduce likelihood of relapse.
• Advising the patient to avoid the cues and triggers associated with cannabis use.

Providing a patient with information about withdrawal symptoms may help them to prepare for discomfort, which if severe can be alleviated with a few days of symptomatic relief. For example:
• Prescribing short-term analgesia and sedation for withdrawal symptoms.
• If irritability and restlessness are marked, a very low dose of diazepam could be prescribed for three to four days.

Most dependent users do not require any drug intervention to manage their withdrawal.

Findings logo commentary Cannabis users make up around a fifth (21%) of adults in substance use treatment in England, and the vast majority (87%) of young people in treatment, according to 2015/16 figures.

For further reading, see the Effectiveness Bank hot topic “Cannabis is worth bothering with”.

Last revised 06 June 2017. First uploaded 01 June 2017

Open Effectiveness Bank home page

Top 10 most closely related documents on this site. For more try a subject or free text search

DOCUMENT 2017 Drug misuse and dependence: UK guidelines on clinical management

DOCUMENT 2009 Management of cannabis use disorder and related issues: a clinician’s guide

DOCUMENT 2012 Practice standards for young people with substance misuse problems

ABSTRACT 2011 Guidance for the use of substitute prescribing in the treatment of opioid dependence in primary care

REVIEW 2012 Meta-analyses of seven of the National Institute on Drug Abuse’s principles of drug addiction treatment

DOCUMENT 2016 Coexisting severe mental illness and substance misuse: community health and social care services

REVIEW 2012 BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP

DOCUMENT 2015 Alcohol-use disorders

DOCUMENT 2009 Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence

DOCUMENT 2013 Delivering recovery. Independent expert review of opioid replacement therapies in Scotland